Literature DB >> 17573339

Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor.

Mathew L Coleman1, Michael A McDonough, Kirsty S Hewitson, Charlotte Coles, Jasmin Mecinovic, Mariola Edelmann, Kristina M Cook, Matthew E Cockman, David E Lancaster, Benedikt M Kessler, Neil J Oldham, Peter J Ratcliffe, Christopher J Schofield.   

Abstract

The stability and activity of hypoxia-inducible factor (HIF) are regulated by the post-translational hydroxylation of specific prolyl and asparaginyl residues. We show that the HIF asparaginyl hydroxylase, factor inhibiting HIF (FIH), also catalyzes hydroxylation of highly conserved asparaginyl residues within ankyrin repeat (AR) domains (ARDs) of endogenous Notch receptors. AR hydroxylation decreases the extent of ARD binding to FIH while not affecting signaling through the canonical Notch pathway. ARD proteins were found to efficiently compete with HIF for FIH-dependent hydroxylation. Crystallographic analyses of the hydroxylated Notch ARD (2.35A) and of Notch peptides bound to FIH (2.4-2.6A) reveal the stereochemistry of hydroxylation on the AR and imply that significant conformational changes are required in the ARD fold in order to enable hydroxylation at the FIH active site. We propose that ARD proteins function as natural inhibitors of FIH and that the hydroxylation status of these proteins provides another oxygen-dependent interface that modulates HIF signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17573339     DOI: 10.1074/jbc.M704102200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  87 in total

1.  Factor inhibiting HIF (FIH) recognizes distinct molecular features within hypoxia-inducible factor-α (HIF-α) versus ankyrin repeat substrates.

Authors:  Sarah E Wilkins; Sarah Karttunen; Rachel J Hampton-Smith; Iain Murchland; Anne Chapman-Smith; Daniel J Peet
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

Review 2.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

3.  Prevention of apoptosis by the interaction between FIH1 and Bax.

Authors:  Biao Yan; Men Kong; Yi-han Chen
Journal:  Mol Cell Biochem       Date:  2010-11-11       Impact factor: 3.396

Review 4.  Complex role of the HIF system in cardiovascular biology.

Authors:  Gabor Czibik
Journal:  J Mol Med (Berl)       Date:  2010-06-24       Impact factor: 4.599

5.  MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism.

Authors:  Han Peng; Robert B Hamanaka; Julia Katsnelson; Liang-Liang Hao; Wending Yang; Navdeep S Chandel; Robert M Lavker
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

Review 6.  New Insights into Protein Hydroxylation and Its Important Role in Human Diseases.

Authors:  Giada Zurlo; Jianping Guo; Mamoru Takada; Wenyi Wei; Qing Zhang
Journal:  Biochim Biophys Acta       Date:  2016-09-20

7.  Biological regulation via ankyrin repeat folding.

Authors:  Doug Barrick
Journal:  ACS Chem Biol       Date:  2009-01-16       Impact factor: 5.100

8.  Post-translational modifications of connexin26 revealed by mass spectrometry.

Authors:  Darren Locke; Shengjie Bian; Hong Li; Andrew L Harris
Journal:  Biochem J       Date:  2009-12-10       Impact factor: 3.857

Review 9.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

Review 10.  Notch signalling in ischaemia-induced angiogenesis.

Authors:  Ayman Al Haj Zen; Paolo Madeddu
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.